Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in one NDA. There are eight patents protecting this drug. This drug…
The post New patent for Global Blood drug OXBRYTA appeared first on DrugP…
Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in one NDA. There are eight patents protecting this drug. This drug…
The post New patent for Global Blood drug OXBRYTA appeared first on DrugP…
This chart shows the pharmaceutical companies with the most suspension dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suspension dosed drugs…
The post Which pharmaceutical companies have the mos…
Which pharmaceutical companies have the most suspension dosed drugs? Read Post »
This chart shows the pharmaceutical companies with the most suspension dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suspension dosed drugs…
The post Which pharmaceutical companies have the mos…
Which pharmaceutical companies have the most suspension dosed drugs? Read Post »
Annual Drug Patent Expirations for LIVALO Livalo is a drug marketed by Kowa Co and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Kowa Co drug LIVALO appeared first on DrugPatentWa…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Italy? Read Post »
Annual Drug Patent Expirations for ZEPOSIA Zeposia is a drug marketed by Celgene Intl and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Celgene Intl drug ZEPOSIA appeared first on DrugPatent…
Annual Drug Patent Expirations for SOOLANTRA Soolantra is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers. There are eleven…
The post New patent for Galderma Labs drug SOOLANTRA appeared first on Dru…
This chart shows the pharmaceutical companies with the most patents in Slovakia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pat…
Which pharmaceutical companies have the most drug patents in Slovakia? Read Post »
Annual Drug Patent Expirations for OPSUMIT Opsumit is a drug marketed by Actelion and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent for Actelion drug OPSUMIT appeared first on DrugPate…
Get new actionable insights and updates from BiotechBlog
